169 related articles for article (PubMed ID: 9106335)
1. Characterization of anti-thymoglobulin, anti-Atgam and anti-OKT3 IgG antibodies in human serum with an 11-min ELISA.
Regan J; Campbell K; van Smith L; Pouletty P; Schroeder TJ; Guttmann RD; Buelow R
Transpl Immunol; 1997 Mar; 5(1):49-56. PubMed ID: 9106335
[TBL] [Abstract][Full Text] [Related]
2. Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay. US Thymoglobulin Multi-Center Study Group.
Regan JF; Campbell K; Van Smith L; Schroeder TJ; Womble D; Kano J; Buelow R
Transpl Immunol; 1999 Jun; 7(2):115-21. PubMed ID: 10544442
[TBL] [Abstract][Full Text] [Related]
3. Cross-species reactivity of the anti-idiotype anti-OKT3 cascade between mice and humans.
Carreno M; Fuller L; Zucker K; Yang WC; Burke G; Nery J; Gomez C; Esquenazi V; Miller J
Hum Immunol; 1992 Apr; 33(4):249-58. PubMed ID: 1386353
[TBL] [Abstract][Full Text] [Related]
4. Removal of therapeutic anti-lymphocyte antibodies from human sera prior to anti-human leukocyte antibody testing.
Bearden CM; Book BK; Sidner RA; Pescovitz MD
J Immunol Methods; 2005 May; 300(1-2):192-9. PubMed ID: 15896799
[TBL] [Abstract][Full Text] [Related]
5. The OKT3 Antibody Response Study: a multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ transplantation.
Kimball JA; Norman DJ; Shield CF; Schroeder TJ; Lisi P; Garovoy M; O'Connell JB; Stuart F; McDiarmid SV; Wall W
Transpl Immunol; 1995 Sep; 3(3):212-21. PubMed ID: 8581409
[TBL] [Abstract][Full Text] [Related]
6. Rapid serologic diagnosis of serum sickness from antithymocyte globulin therapy using enzyme immunoassay.
Tatum AH; Bollinger RR; Sanfilippo F
Transplantation; 1984 Dec; 38(6):582-6. PubMed ID: 6334386
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antimouse and antihorse antibody production during the treatment of allograft rejection with OKT3 or antithymocyte globulin.
Shield CF; Norman DJ; Marlett P; Fucello AJ; Goldstein G
Nephron; 1987; 46 Suppl 1():48-51. PubMed ID: 3306425
[TBL] [Abstract][Full Text] [Related]
8. Detection of IGA anti-OKT3 antibodies in OKT3-treated transplant recipients.
McIntyre JA; Kincade M; Higgins NG
Transplantation; 1996 May; 61(10):1465-9. PubMed ID: 8633372
[TBL] [Abstract][Full Text] [Related]
9. The IgE humoral response in OKT3-treated patients. Incidence and fine specificity.
Abramowicz D; Crusiaux A; Niaudet P; Kreis H; Chatenoud L; Goldman M
Transplantation; 1996 Feb; 61(4):577-81. PubMed ID: 8610384
[TBL] [Abstract][Full Text] [Related]
10. Antibody response to OKT3 and methods for monitoring.
Schroeder TJ; Hariharan S; First MR
Transplant Proc; 1993 Apr; 25(2 Suppl 1):77-80. PubMed ID: 8465433
[TBL] [Abstract][Full Text] [Related]
11. Total and active thymoglobulin levels: effects of dose and sensitization on serum concentrations.
Regan JF; Lyonnais C; Campbell K; Smith LV; Buelow R;
Transpl Immunol; 2001 Oct; 9(1):29-36. PubMed ID: 11680569
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression.
Jaffers GJ; Fuller TC; Cosimi AB; Russell PS; Winn HJ; Colvin RB
Transplantation; 1986 May; 41(5):572-8. PubMed ID: 3085297
[TBL] [Abstract][Full Text] [Related]
13. Rapid detection of anti-OKT3 antibodies with the Transtat assay.
Schroeder TJ; First MR; Pouletty C; Hariharan S; Pouletty P
Transplantation; 1993 Feb; 55(2):297-9. PubMed ID: 8434379
[TBL] [Abstract][Full Text] [Related]
14. Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry.
Bourdage JS; Hamlin DM
Transplantation; 1995 Apr; 59(8):1194-200. PubMed ID: 7732566
[TBL] [Abstract][Full Text] [Related]
15. Reduced human IgG anti-ATGAM antibody formation in renal transplant recipients receiving mycophenolate mofetil.
Kimball JA; Pescovitz MD; Book BK; Norman DJ
Transplantation; 1995 Dec; 60(12):1379-83. PubMed ID: 8545860
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.
Brennan DC; Flavin K; Lowell JA; Howard TK; Shenoy S; Burgess S; Dolan S; Kano JM; Mahon M; Schnitzler MA; Woodward R; Irish W; Singer GG
Transplantation; 1999 Apr; 67(7):1011-8. PubMed ID: 10221486
[TBL] [Abstract][Full Text] [Related]
17. OKT3 antibody response study: comparative testing of human antimouse antibody.
Kimball JA; Norman DJ; Shield CF; Schroeder TJ; Lisi P; Garovoy M; O'Connell JB; Stuart F; McDiarmid SV; Wall W
Transplant Proc; 1993 Apr; 25(2 Suppl 1):74-6. PubMed ID: 8465432
[No Abstract] [Full Text] [Related]
18. Anti-OKT3 response following prophylactic treatment in paediatric kidney transplant recipients.
Niaudet P; Jean G; Broyer M; Chatenoud L
Pediatr Nephrol; 1993 Jun; 7(3):263-7. PubMed ID: 8518095
[TBL] [Abstract][Full Text] [Related]
19. OKT3 induction via idiotypic networks of mirror-image immunosuppressive antiimmunoglobulins in renal transplant recipients.
Carreno M; Yang WC; Esquenazi V; Fuller L; Burke G; Milgrom M; Roth D; Ranjan D; Miller J
Transplantation; 1990 Feb; 49(2):408-15. PubMed ID: 1689519
[TBL] [Abstract][Full Text] [Related]
20. Antilymphocyte induction immunosuppression in the post-Minnesota anti-lymphocyte globulin era: incidence of renal dysfunction and delayed graft function. A single center experience.
Malinow L; Walker J; Klassen D; Oldach D; Schweitzer E; Bartlett ST; Weir MR
Clin Transplant; 1996 Jun; 10(3):237-42. PubMed ID: 8826659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
